Continuation of the Costa Rican Epidemiologic Surveillance for Invasive Pneumococcal Disease After Introduction of the Seven Valent Vaccine Into the Universal Vaccination Program.
Phase of Trial: Phase IV
Latest Information Update: 16 May 2014
At a glance
- Drugs Pneumococcal 7-valent CRM197 vaccine conjugate (Primary)
- Indications Pneumococcal infections
- Focus Therapeutic Use
- 25 Mar 2014 Planned End Date changed from 1 Sep 2013 to 1 Mar 2014 as reported by ClinicalTrials.gov record.
- 25 Mar 2014 Status changed from recruiting to suspended as reported by ClinicalTrials.gov record.
- 05 Dec 2011 Planned end date changed from 1 Jul 2012 to 1 Sep 2013 as reported by ClinicalTrials.gov.